1. Home
  2. MNKD vs UNIT Comparison

MNKD vs UNIT Comparison

Compare MNKD & UNIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • UNIT
  • Stock Information
  • Founded
  • MNKD 1991
  • UNIT 2015
  • Country
  • MNKD United States
  • UNIT United States
  • Employees
  • MNKD N/A
  • UNIT N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • UNIT Real Estate Investment Trusts
  • Sector
  • MNKD Health Care
  • UNIT Real Estate
  • Exchange
  • MNKD Nasdaq
  • UNIT Nasdaq
  • Market Cap
  • MNKD 1.1B
  • UNIT 1.1B
  • IPO Year
  • MNKD 2004
  • UNIT N/A
  • Fundamental
  • Price
  • MNKD $4.06
  • UNIT $5.80
  • Analyst Decision
  • MNKD Buy
  • UNIT Buy
  • Analyst Count
  • MNKD 6
  • UNIT 4
  • Target Price
  • MNKD $9.33
  • UNIT $5.95
  • AVG Volume (30 Days)
  • MNKD 3.0M
  • UNIT 2.6M
  • Earning Date
  • MNKD 08-06-2025
  • UNIT 08-05-2025
  • Dividend Yield
  • MNKD N/A
  • UNIT N/A
  • EPS Growth
  • MNKD 228.27
  • UNIT N/A
  • EPS
  • MNKD 0.10
  • UNIT 0.23
  • Revenue
  • MNKD $297,595,000.00
  • UNIT $1,174,418,000.00
  • Revenue This Year
  • MNKD $13.72
  • UNIT $101.56
  • Revenue Next Year
  • MNKD $14.94
  • UNIT $58.21
  • P/E Ratio
  • MNKD $39.14
  • UNIT $25.44
  • Revenue Growth
  • MNKD 32.50
  • UNIT 2.44
  • 52 Week Low
  • MNKD $3.51
  • UNIT $3.50
  • 52 Week High
  • MNKD $7.63
  • UNIT $6.31
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 55.84
  • UNIT 81.20
  • Support Level
  • MNKD $3.74
  • UNIT $4.18
  • Resistance Level
  • MNKD $4.13
  • UNIT $4.77
  • Average True Range (ATR)
  • MNKD 0.14
  • UNIT 0.23
  • MACD
  • MNKD 0.05
  • UNIT 0.14
  • Stochastic Oscillator
  • MNKD 88.14
  • UNIT 96.10

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About UNIT Uniti Group Inc.

Uniti is a REIT with about 140,000 route miles of fiber in the us, primarily in the Southeast. It has agreed to merge with Windstream, which will result in Uniti giving up its REIT status and adding a consumer telecom business line. Uniti's business currently consists exclusively of fiber leasing to enterprises. Windstream currently leases the Uniti network and makes up the bulk of Uniti's revenue and profits. The combined firm will own 217,000 route miles of fiber and pass 4.3 million households and 150,000 commercial buildings, mostly in less populated markets in the Southeast. The firm will continue to offer fiber access to enterprises, as Uniti currently does, but residential telecom services will become its largest revenue stream.

Share on Social Networks: